: iStockAnalyst.com Symbols Feed

Few Thoughts and a Look at the Earnings in the Coming Week

Mon, 28 Jul 2008 05:15:00 GMT

WITH RESPECT TO THE US’ GDP GROWTH, THE NATIONAL BUREAU OF ECONOMIC RESEARCH SEES A SIGNIFICANT DECLINE IN ECONOMIC ACTITIVY SPREAD ACROSS THE ECONOMY, WHICH WILL LAST MORE THAN A FEW MONTHS - WSJ - According to Robert Hall, economist at Stanford University, US economic data that has been reported provide (...)[More...]

BioMed Realty Trust Commemorates Five-Year Anniversary As a Public Company ; Ringing NYSE Closing Bell(R) Today; Provides Tenant Update

Thu, 06 Aug 2009 10:48:00 GMT

SAN DIEGO, Aug. 6 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR), The Leading Provider of Real Estate to the Life Science Industry(R), announced today that its board of directors and corporate officers will ring The Closing Bell(R) at the New York Stock Exchange on Thursday, August 6, 2009 at 4:00 p.m. Eastern Time to commemorate the fifth anniversary of the company's initial public offering.
BioMed's founders, Alan D. Gold, Chairman and Chief Executive Officer, and Gary A. Kreitzer, Executive Vice President, General Counsel and Director, will preside over the ringing of The Closing Bell(R).
"This is a great day for our team," said Mr. Gold.

[More...]

BioMed Realty Trust Commemorates Five-Year Anniversary as a Public Company

Thu, 06 Aug 2009 09:56:00 GMT

BioMed Realty Trust, Inc. , The Leading Provider of Real Estate to the Life Science Industry, announced today that its board of directors and corporate officers will ring The Closing Bell at the New York Stock Exchange on Thursday, August 6, 2009 at 4:00 p.m. Eastern Time to commemorate the fifth anniversary of the company's initial public offering. The ceremony will take place at the New York Stock Exchange, 11 Wall Street in New York City. BioMed's founders, Alan D. Gold, Chairman and Chief Executive Officer, and Gary A. Kreitzer, Executive Vice President, General Counsel and Director, will preside over the ringing of The Closing Bell.[More...]

BioMed Realty Trust Reports Second Quarter 2009 Operating and Financial Results

Wed, 29 Jul 2009 22:26:00 GMT

BioMed Realty Trust, Inc. , a real estate investment trust focused on Providing Real Estate to the Life Science Industry, today announced operating and financial results for the second quarter ended June 30, 2009.[More...]

BioMed Realty Trust To Report 2009 Second Quarter Results

Wed, 22 Jul 2009 19:31:00 GMT

BioMed Realty Trust, Inc. today announced it will report results for its second quarter ended June 30, 2009 after the market closes on Wednesday, July 29, 2009. Alan D. Gold, Chairman and Chief Executive Officer, and Kent Griffin, President and Chief Financial Officer, will host an investor conference call at 10:00 a.m. Pacific Time on Thursday, July 30, 2009 to discuss the company's financial results and operations for the quarter. The call will be open to all interested investors either through a live audio web cast at the Investor Relations section of the company's web site at www.biomedrealty.com and at www.earnings.com, or live by calling 866.543.6407 or 617.213.8898 with call ID number 46945553. The call will be archived for 30 days on both web sites. A telephone playback of the conference call will also be available from 1:00 p.m. Pacific Time on Thursday, July 30, 2009 until midnight Pacific Time on Tuesday, August 4, 2009 by calling 888.286.8010 or 617.801.6888 and using access code 12764871.About BioMed Realty TrustBioMed Realty Trust, Inc. is a real estate investment trust focused on Providing Real Estate to the Life Science Industry. The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed Realty Trust owns or has interests in 69 properties, representing 112 buildings with approximately 10.5 million rentable square feet, including approximately 280,000 square feet of development in progress. The company also owns undeveloped land parcels adjacent to existing properties that it estimates can support up to 1.4 million rentable square feet. The company's properties are located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey, which have well-established reputations as centers for scientific research. Additional information is available at www.biomedrealty.com. Media Contact[More...]

Bradmer to repurchase up to 8.3 million of its common shares pursuant to a substantial issuer bid

Fri, 17 Jul 2009 10:56:00 GMT

TSX: BMR[More...]

BioMed Realty Trust Completes $350 Million Financing for Center for Life Science | Boston

Mon, 29 Jun 2009 22:30:00 GMT

BioMed Realty Trust, Inc. announced today the closing of a new $350 million loan with John Hancock Life Insurance Company, TIAA-CREF, and Westdeutsche ImmobilienBank AG. The five year loan is secured by a single property - the Center for Life Science | Boston, a newly constructed 700,000+ square foot state-of-the-art research facility that recently received Gold LEED certification from the U.S. Green Building Council.[More...]

BioMed Realty Trust Closes New $18 Million Secured Loan

Mon, 22 Jun 2009 11:56:00 GMT

BioMed Realty Trust Closes New $18 Million Secured Loan[More...]

BioMed Realty Trust Declares Second Quarter 2009 Common Stock and Preferred Stock Dividends

Tue, 16 Jun 2009 03:46:00 GMT

SAN DIEGO, June 15 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. today announced that its board of directors has declared a second quarter 2009 dividend of $0.11 per share of common stock.
BioMed also announced that its board of directors has declared a dividend of $0.46094 per share of the company's 7.375% Series A Cumulative Redeemable Preferred Stock for the period from April 16, 2009 through July 15, 2009.
About BioMed Realty Trust

[More...]

BioMed Realty Trust Declares Second Quarter 2009 Common Stock and Preferred Stock Dividends

Mon, 15 Jun 2009 21:49:00 GMT

SAN DIEGO, June 15 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its board of directors has declared a second quarter 2009 dividend of $0.11 per share of common stock.
BioMed also announced that its board of directors has declared a dividend of $0.46094 per share of the company's 7.375% Series A Cumulative Redeemable Preferred Stock for the period from April 16, 2009 through July 15, 2009.
About BioMed Realty Trust

[More...]

BioMed Realty Trust Prices Public Offering of 16,000,000 Shares of Common Stock

Wed, 13 May 2009 13:47:00 GMT

SAN DIEGO, May 13 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. today announced the pricing of its public offering of 16,000,000 shares of its common stock at $10.40 per share.
Gross proceeds from the offering will be approximately $166.4 million.
Raymond James & Associates, Inc., KeyBanc Capital Markets Inc., Morgan Stanley & Co. Incorporated, UBS Securities LLC, Wachovia Capital Markets, LLC and Credit Suisse Securities (USA) LLC are the joint book-running managers for the offering.

[More...]